Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Visual Inspection of Semi-Solid Intermediates – V 2.0

Posted on By

API Manufacturing: SOP for Visual Inspection of Semi-Solid Intermediates – V 2.0

Standard Operating Procedure for Visual Inspection of Semi-Solid Intermediates in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/096/2025
Supersedes SOP/API/096/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define the standard procedure for performing visual inspection of semi-solid intermediates during API manufacturing for monitoring appearance, color, uniformity, and identification of foreign particles or physical non-conformities.

2. Scope

This SOP applies to semi-solid intermediates such as wet cake, slurry, or partially dried mass generated during the synthesis and isolation stages of API production.

3. Responsibilities

  • Production Chemist: Perform routine visual inspections during each processing stage and record observations.
  • QC Analyst: Assist in confirming and documenting any abnormalities detected during inspection.
  • QA Officer: Review records and approve or reject batches based on inspection findings and risk assessment.
See also  API Manufacturing: SOP for Cleaning Validation Between Batches - V 2.0

4. Accountability

Production Head is accountable for conducting inspections. QA Head is accountable for reviewing outcomes and ensuring GMP compliance.

5. Procedure

5.1 Inspection Conditions

  1. Perform inspection under good illumination (minimum 1000 lux) and neutral background (preferably white or grey).
  2. Wear gloves, mask, and protective garments to avoid contamination.
  3. Use a clean stainless-steel spatula to collect a small quantity of the intermediate into a glass or SS dish for evaluation.

5.2 Visual Parameters

  1. Observe and record the following parameters:
    • Color: Compare with expected color range mentioned in the BMR or MFR.
    • Consistency: Evaluate whether the intermediate is homogenous, lumpy, granular, pasty, or oily.
    • Phase Separation: Check for any liquid phase settling in slurry or semi-solid form.
    • Foreign Matter: Inspect for presence of fibers, dust, glass, rubber particles, metal fragments, or black spots.
    • Odor (if applicable): Smell should be characteristic and within acceptable threshold.
See also  API Manufacturing: SOP for Use of Vibratory Sifter in API Processing - V 2.0

5.3 Acceptance Criteria

  1. Color, consistency, and odor should match with standard batch or MFR description.
  2. No visible foreign particles should be present. If found, segregate sample and escalate for investigation.
  3. If inconsistencies are observed in uniformity, perform mixing or homogenization and reinspect.

5.4 Documentation

  1. Record findings in the Visual Inspection Logbook (Annexure-1) with date, batch number, stage, and initials.
  2. Affix photograph (if required by protocol or investigation).
  3. For deviations, initiate deviation form and seek QA decision before further processing.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • BMR: Batch Manufacturing Record
  • MFR: Master Formula Record
See also  API Manufacturing: SOP for Color and Odor Assessment in Intermediates - V 2.0

7. Documents

  1. Visual Inspection Logbook (Annexure-1)
  2. Batch Manufacturing Record
  3. Deviation Form (if required)

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • 21 CFR Part 211 – US FDA GMP
  • WHO TRS 986 – GMP Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Visual Inspection Logbook

Date Batch No. Stage Observed Color Consistency Foreign Matter Performed By Remarks
13/04/2025 API-20250413 Post-Filtration Pale Yellow Homogeneous Slurry None Complies

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release Process Visual Control QA Head
13/04/2025 2.0 Added Criteria for Odor and Photo Documentation Audit Compliance QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: BA-BE Studies: SOP for Documenting Protocol Violations and CAPA – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version